Hosted on MSN28m
FDA grants ODD to NMD Pharma’s Charcot-Marie-Tooth disease therapy
The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to NMD Pharma’s oral lead development programme, NMD670, designed to treat Charcot-Marie-Tooth disease (CMT). A ...
Sponsored: Pine Rest offers non-medication relief for depression and OCD
About a third of them do not achieve adequate relief from traditional antidepressant medications and psychotherapy. The Pine ...
India Today37m
Toxic Lead in baby food: FDA sets new safety standards
The FDA set voluntary lead limits in baby foods, aiming to reduce exposure by 20-30%. Critics welcome the move but call it insufficient, as some foods remain unregulated and standards prioritize ...